Neurotoxic and cytotoxic peptides underlie the painful stings of the tree nettle Urtica ferox.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
08 2022
Historique:
received: 26 01 2022
revised: 22 06 2022
accepted: 28 06 2022
pubmed: 6 7 2022
medline: 9 9 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

The stinging hairs of plants from the family Urticaceae inject compounds that inflict pain to deter herbivores. The sting of the New Zealand tree nettle (Urtica ferox) is among the most painful of these and can cause systemic symptoms that can even be life-threatening; however, the molecular species effecting this response have not been elucidated. Here we reveal that two classes of peptide toxin are responsible for the symptoms of U. ferox stings: Δ-Uf1a is a cytotoxic thionin that causes pain via disruption of cell membranes, while β/δ-Uf2a defines a new class of neurotoxin that causes pain and systemic symptoms via modulation of voltage-gated sodium (Na

Identifiants

pubmed: 35780839
pii: S0021-9258(22)00660-3
doi: 10.1016/j.jbc.2022.102218
pmc: PMC9352542
pii:
doi:

Substances chimiques

Neurotoxins 0
Peptides 0
Toxins, Biological 0
Voltage-Gated Sodium Channels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102218

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Jing Xie (J)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Samuel D Robinson (SD)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Edward K Gilding (EK)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Sina Jami (S)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Jennifer R Deuis (JR)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Fabian B H Rehm (FBH)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Kuok Yap (K)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Lotten Ragnarsson (L)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Lai Yue Chan (LY)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Brett R Hamilton (BR)

Centre for Microscopy and Microanalysis, The University of Queensland, Brisbane, Queensland, Australia.

Peta J Harvey (PJ)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

David J Craik (DJ)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, Queensland, Australia.

Irina Vetter (I)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia; School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: i.vetter@imb.uq.edu.au.

Thomas Durek (T)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: t.durek@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH